Tower Research Capital (TRC)’s Avantis US Equity ETF AVUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-1,717
Closed -$191K 5212
2026
Q1
$191K Buy
+1,717
New +$197K 0.01% 1659
2025
Q4
Sell
-4,249
Closed -$462K 5142
2025
Q3
$462K Buy
4,249
+1,715
+68% +$180K 0.01% 916
2025
Q2
$255K Sell
2,534
-1,902
-43% -$178K 0.01% 1562
2025
Q1
$410K Buy
+4,436
New +$432K 0.01% 951
2024
Q2
Sell
-1,622
Closed -$145K 5681
2024
Q1
$145K Buy
+1,622
New +$137K ﹤0.01% 1619
2023
Q4
Sell
-1,099
Closed -$80.5K 5913
2023
Q3
$80.5K Sell
1,099
-1,294
-54% -$98.3K ﹤0.01% 2143
2023
Q2
$180K Sell
2,393
-10,527
-81% -$753K 0.01% 1634
2023
Q1
$915K Sell
12,920
-9,816
-43% -$695K 0.03% 499
2022
Q4
$1.55M Buy
+22,736
New +$1.55M 0.06% 229
2022
Q3
Sell
-427
Closed -$28K 6049
2022
Q2
$28K Buy
+427
New +$30.3K ﹤0.01% 3432

Other funds holding AVUS

Tower Research Capital (TRC)'s AVUS Position: Q2 2026 in Review

Tower Research Capital (TRC) sold out of Avantis US Equity ETF (AVUS) in Q2 2026, closing a stake of 1,717 shares — an estimated $191K sold.

Tower Research Capital (TRC) first reported a position in AVUS in Q2 2022 and held it in 10 quarters. The position peaked at $1.55M in Q4 2022. 582 funds tracked by Wall St. Rank hold AVUS as of Q2 2026.

  • Tower Research Capital (TRC) reported no remaining Avantis US Equity ETF position as of Q2 2026 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 1,717 Avantis US Equity ETF shares in Q2 2026, an estimated $191K.
  • Tower Research Capital (TRC) first reported a position in Avantis US Equity ETF in Q2 2022 and held it in 10 quarters.
  • Tower Research Capital (TRC)'s Avantis US Equity ETF position peaked at $1.55M in Q4 2022.
  • 582 funds tracked by Wall St. Rank held Avantis US Equity ETF as of Q2 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.